1. AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy. (March 2018) Authors: Schindler, U.; Seitz, L.; Ashok, D.; Piovesan, D.; Tan, J.; DiRenzo, D.; Yin, F.; Leleti, M.; Rosen, B.; Miles, D.; Jin, L.; Park, T.; Young, S.; Soriano, F.; Rieger, A.; Karakunnel, J.; Sharif, E.; Powers, J.P.; Walters, M.J. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discovery and characterization of novel, potent, and selective hypoxiainducible factor (HIF)-2α inhibitors. (October 2020) Authors: Lawson, K.; Gauthier, K. Sivick; Piovesan, D.; Fournier, J.; Rosen, B.; Maliyan, A.; Beatty, J.; Jin, L.; Leleti, M.; Ginn, E.; Udyavar, A.; Ada, C.; Au, J.; Meleza, C.; Zhao, S.; Young, S.; Walters, M.; Powers, J. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discovery and characterization of potent and selective AXL receptor tyrosine kinase inhibitor AB801. (October 2022) Authors: Miles, D.; Paprcka, S.; Foley, C.; Qu, S.; Lamani, M.; Paladugu, S.; Huang, H.T.; Tibrewal, N.; Chen, A.; Kulusich, J.; Garrido-Shaqfeh, S.; Fabila, P.; Sridhar, S.; Liu, S.; Swinarski, D.; Zhao, X.; Fernandez-Salas, E.; Green, D.; Jin, L.; Leleti, M. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0002 Inhibition of chemokine receptors ccr1 and ccr6 as promising therapies for rheumatoid arthritis. (23rd January 2014) Authors: Jaen, J. C.; Dairaghi, D.; Leleti, M.; Powers, J. P.; Wang, Y.; Zhang, P.; Schall, T. J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Novel small-molecule inhibitors of ecto-nucleotidase CD73: Activation of human CD8+ T cells and effects on tumor growth and immune parameters in experimental tumor models. (December 2016) Authors: Schindler, U.; Chen, A.; Leleti, M.; Sharif, E.; Miles, D.; Powers, J.; Tan, J.; Sexton, H.; Park, T.; Young, S.; Jaen, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0204 Characterization of the novel C5AR antagonist CCX168, a potential therapeutic for ANCA-vasculitis, rheumatoid arthritis, and other autoimmune disorders. (23rd January 2014) Authors: Powers, J.P.; Bekker, P.J.; Dairaghi, D.J.; Jennette, J.C.; Johnson, D.A.; Leleti, M.; Miao, S.; Seitz, L.C.; Wang, Y.; Xiao, H.; Schall, T.J.; Jaen, J.C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗